Unlocking the Potential of Ancient Enzymes: A Dive into Cutting-edge Therapeutics Development | Sanjay Shukla , CEO, aTyr Pharma Inc. 00:10:00

Share On Facebook Share On Twitter

Exploring the complex world of biotechnology, this interview delves into Atossa Pharma's mission to harness trna synthetase biology for developing innovative therapeutics targeting inflammatory, fibrotic diseases, and cancer, emphasizing a data-driven approach and a vast pipeline of potential treatments.

Recent Videos